Brief: Guard Therapeutics Gets Intention To Grant Notice In Europe For ROSgard

Disruptive Pharma AB (publ)

09/04/2021 07:37

April 9 (Reuters) - Guard Therapeutics International AB
(publ)  GUARD.ST :
    * GUARD THERAPEUTICS RECEIVES AN INTENTION TO GRANT NOTICE
IN
EUROPE FOR ROSGARD
    * INTENTION TO GRANT NOTICE FROM EUROPEAN PATENT OFFICE
(EPO) FOR
A PATENT APPLICATION CONCERNING ITS BIOLOGICAL INVESTIGATIONAL
DRUG ROSGARD AS A PRODUCT, INCLUDING ITS MEDICAL USE
    * NEXT STEP IN PROCESS IS A FORMAL EPO APPROVAL, WHICH
PROVIDES A
PATENT PROTECTION UNTIL 2037

Source text for Eikon:  ID:nMFNYrbw1 
Further company coverage:  GUARD.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))